Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

Alzheimer s & Dementia(2025)10.1002/alz.70309Source: DataRank Database

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)Impact (FWCI 5.47)OA: hybridTopics (21)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (59)

Lucía Maure-Blesa ORCID,Beau M. Ances ORCID,Lisi Flores Aguilar ORCID,Sigan L. Hartley ORCID,Jason Hassenstab ORCID

Live enrichment

PubMed:40604347 PMC:PMC12221810 OpenAlex:https://openalex.org/W4411939454

Global Brain Health Institute

Grant: GBHI_ALZ‐18‐543740

Alzheimer's Association

Grant: AARG‐22‐923680

Agence Nationale de la Recherche

Grant: DYRK‐DOWN

Fondation Jérôme Lejeune

Grant: 2326 ‐ GRT‐2024A

Instituto de Salud Carlos III

Grant: JR22/00014

Instituto de Salud Carlos III

Grant: CD23/00235

Instituto de Salud Carlos III

Grant: CM22/00052

Instituto de Salud Carlos III

Grant: CM22/00219

Instituto de Salud Carlos III

Grant: CM21/00243

Instituto de Salud Carlos III

Grant: CP20/00038

Instituto de Salud Carlos III

Grant: CP24/00112

Instituto de Salud Carlos III

Grant: CM23/00291

Fondation Jérôme Lejeune

Grant: 2326 - GRT-2024A

European Innovation Council (EIC), Accelerator Program

Grant: 190138295

Agence Nationale de la Recherche (ANR), France 2030, Bpifrance, European Union's Horizon 2020 research and innovation program

Grant: GO-DS21

Global Brain Health Institute

Grant: GBHI_ALZ-18-543740

Alzheimer's Association

Grant: AARG-22-923680

Agence Nationale de la Recherche

Grant: DYRK-DOWN

NIA NIH HHS

Grant: P30 AG066530

Alzheimer's Association ISTAART Conference Support Award

UK Medical Research Council, UK NIHR UCLH Biomedical Research Centre, Dominantly Inherited Alzheimer Network

Ministerio de Ciencias Innovación y Universidades

National Institute on Aging

UK Dementia Research Institute

Fondos FEDER

Fundación Catalana del Síndrome de Down (FCSD)

Fundación Pasqual Maragall

FWCI

5.47

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70309

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70309

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.70309

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.70309

journalhttps://doi.org/10.1002/alz.70309

Fields of Study

Down syndrome and intellectual disability researchGenomics and Rare DiseasesGenetic Neurodegenerative DiseasesMedicine

MeSH Terms

Alzheimer DiseaseCongresses as TopicDown SyndromeHumansBiomarkersBiomedical Research

Keywords

DiseaseAlzheimer's diseaseMedicineClinical trialPathologyBiomarkersPathophysiologyDown syndromeClinical TrialsNeuroimagingAutosomal Dominant Alzheimer's Disease

Sustainable Development Goals

SDG 0: Partnerships for the goals